Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Defects, Congenital | 15 | 2020 | 933 | 3.57 | Why? |
| Neonatal Screening | 3 | 2018 | 285 | 1.62 | Why? |
| Preconception Care | 1 | 2019 | 49 | 0.80 | Why? |
| Arterial Switch Operation | 1 | 2018 | 20 | 0.75 | Why? |
| Cardiomegaly | 1 | 2019 | 96 | 0.75 | Why? |
| Transposition of Great Vessels | 1 | 2018 | 30 | 0.74 | Why? |
| Systemic Inflammatory Response Syndrome | 12 | 2021 | 6653 | 0.74 | Why? |
| Fontan Procedure | 1 | 2018 | 42 | 0.73 | Why? |
| Systolic Murmurs | 1 | 2017 | 1 | 0.71 | Why? |
| Heart Sounds | 1 | 2017 | 2 | 0.71 | Why? |
| Heart Auscultation | 1 | 2017 | 6 | 0.70 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2019 | 231 | 0.63 | Why? |
| Infant Mortality | 2 | 2018 | 268 | 0.62 | Why? |
| State Government | 2 | 2017 | 416 | 0.61 | Why? |
| Oximetry | 2 | 2018 | 658 | 0.61 | Why? |
| Cardiac Surgical Procedures | 4 | 2019 | 1931 | 0.55 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.52 | Why? |
| Mandatory Programs | 1 | 2017 | 291 | 0.51 | Why? |
| Hospital Costs | 2 | 2014 | 274 | 0.51 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.50 | Why? |
| Heart Diseases | 2 | 2021 | 3503 | 0.50 | Why? |
| Child Development | 1 | 2017 | 352 | 0.49 | Why? |
| Heart Valve Diseases | 1 | 2017 | 355 | 0.48 | Why? |
| Tetralogy of Fallot | 1 | 2012 | 43 | 0.48 | Why? |
| Cardiologists | 1 | 2017 | 366 | 0.46 | Why? |
| Aftercare | 1 | 2021 | 1637 | 0.45 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.41 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.41 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.39 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.38 | Why? |
| Infant | 17 | 2021 | 30274 | 0.35 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.34 | Why? |
| Infant, Newborn | 14 | 2021 | 23105 | 0.33 | Why? |
| Guideline Adherence | 1 | 2019 | 2309 | 0.31 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.29 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.26 | Why? |
| Child | 21 | 2021 | 70012 | 0.24 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.24 | Why? |
| Radiography, Thoracic | 1 | 2019 | 5486 | 0.23 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.23 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.23 | Why? |
| Hypertrophy, Right Ventricular | 1 | 2021 | 33 | 0.23 | Why? |
| Child, Preschool | 13 | 2021 | 36283 | 0.23 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.22 | Why? |
| Ventricular Premature Complexes | 1 | 2021 | 42 | 0.22 | Why? |
| Length of Stay | 4 | 2020 | 11042 | 0.22 | Why? |
| Atrioventricular Block | 1 | 2021 | 105 | 0.20 | Why? |
| Pulmonary Atresia | 1 | 2019 | 11 | 0.20 | Why? |
| Brain | 1 | 2017 | 5133 | 0.19 | Why? |
| Retrospective Studies | 17 | 2021 | 105322 | 0.19 | Why? |
| Health Resources | 1 | 2012 | 2592 | 0.19 | Why? |
| United States | 14 | 2021 | 46150 | 0.19 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.19 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2021 | 219 | 0.18 | Why? |
| Scimitar Syndrome | 1 | 2017 | 9 | 0.18 | Why? |
| Syncope | 1 | 2021 | 238 | 0.18 | Why? |
| Hypoxia | 3 | 2018 | 3626 | 0.17 | Why? |
| Thyrotropin | 1 | 2019 | 262 | 0.17 | Why? |
| Bradycardia | 1 | 2021 | 292 | 0.17 | Why? |
| Vital Statistics | 1 | 2017 | 89 | 0.17 | Why? |
| Birth Certificates | 1 | 2017 | 34 | 0.17 | Why? |
| American Heart Association | 1 | 2019 | 347 | 0.17 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.17 | Why? |
| Transition to Adult Care | 1 | 2017 | 56 | 0.16 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.16 | Why? |
| Vasoconstrictor Agents | 1 | 2020 | 714 | 0.16 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.16 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.15 | Why? |
| Cyanosis | 1 | 2016 | 100 | 0.15 | Why? |
| Adolescent | 15 | 2021 | 86841 | 0.15 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.15 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.15 | Why? |
| Myocarditis | 2 | 2021 | 2731 | 0.14 | Why? |
| Cardiology | 2 | 2021 | 2873 | 0.14 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.14 | Why? |
| Female | 25 | 2021 | 380317 | 0.14 | Why? |
| North Carolina | 1 | 2017 | 571 | 0.14 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.14 | Why? |
| Male | 25 | 2021 | 367725 | 0.13 | Why? |
| Insurance, Health | 1 | 2019 | 634 | 0.13 | Why? |
| Blood Cell Count | 1 | 2019 | 1101 | 0.13 | Why? |
| Young Adult | 12 | 2021 | 93724 | 0.13 | Why? |
| Fatal Outcome | 2 | 2020 | 3438 | 0.12 | Why? |
| Exercise Test | 1 | 2019 | 911 | 0.12 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.12 | Why? |
| Humans | 34 | 2021 | 930598 | 0.12 | Why? |
| Aspirin | 1 | 2020 | 1043 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.12 | Why? |
| Practice Guidelines as Topic | 3 | 2021 | 15421 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 1 | 2019 | 1215 | 0.12 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.12 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.11 | Why? |
| Mucocutaneous Lymph Node Syndrome | 2 | 2020 | 1645 | 0.11 | Why? |
| Immunoglobulins, Intravenous | 2 | 2020 | 2705 | 0.11 | Why? |
| Heart | 1 | 2021 | 1791 | 0.11 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.11 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.11 | Why? |
| Obstetrics | 1 | 2019 | 859 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.10 | Why? |
| Anemia, Sickle Cell | 1 | 2016 | 546 | 0.10 | Why? |
| Models, Economic | 1 | 2012 | 316 | 0.10 | Why? |
| Down Syndrome | 1 | 2014 | 397 | 0.10 | Why? |
| Time Factors | 6 | 2021 | 31397 | 0.10 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.09 | Why? |
| Educational Measurement | 1 | 2017 | 930 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.09 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.09 | Why? |
| Magnetic Resonance Imaging | 2 | 2021 | 6551 | 0.09 | Why? |
| Registries | 3 | 2018 | 12327 | 0.09 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.08 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.08 | Why? |
| Cost-Benefit Analysis | 1 | 2016 | 2259 | 0.08 | Why? |
| Lymphopenia | 1 | 2018 | 2669 | 0.08 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.07 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.07 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.07 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Diagnostic Imaging | 1 | 2012 | 1044 | 0.07 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.07 | Why? |
| Mortality | 2 | 2018 | 7132 | 0.07 | Why? |
| Critical Care | 3 | 2021 | 14081 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.06 | Why? |
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 56 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Hospitals, Pediatric | 1 | 2012 | 1792 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.05 | Why? |
| Gadolinium | 1 | 2021 | 318 | 0.05 | Why? |
| Infant Death | 1 | 2018 | 7 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.05 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Ventricular Dysfunction | 1 | 2016 | 150 | 0.04 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.04 | Why? |
| Elective Surgical Procedures | 1 | 2012 | 5338 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| History, 21st Century | 1 | 2021 | 1849 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.03 | Why? |
| Georgia | 1 | 2016 | 955 | 0.03 | Why? |
| Developmental Disabilities | 1 | 2016 | 257 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.03 | Why? |
| Florida | 1 | 2014 | 598 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.02 | Why? |
| Cerebrovascular Disorders | 1 | 2016 | 1040 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
Oster's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(268)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_